JOURNAL ARTICLE

Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparation, part 3: risk levels

Loyd V Allen, Claudia C Okeke
International Journal of Pharmaceutical Compounding 2007, 11 (5): 404-10
23969522
The intent of United States Pharmacopeia Chapter 797 Pharmaceutical Compounding-Sterile Preparations is to prevent patient harm and fatalities that may result from nonsterility, excessive endotoxin load, large content errors in strength of correct ingredients, or the presence of incorrect ingredients. Understanding the different microbial contamination risk levels involved in compounding sterile preparations, how to appropriately assign those risk levels, and the steps needed to maintain sterility decreases the probability of a contaminated preparation.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Remove bar
Read by QxMD icon Read
23969522
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"